[HTML][HTML] … obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation
KA Martin, J Beyer‐Westendorf, BL Davidson… - Journal of thrombosis …, 2021 - Elsevier
… Although direct‐acting oral anticoagulants (DOACs) have widespread first‐line use for
treatment and prevention of venous thromboembolism (VTE), uncertainty remains regarding their …
treatment and prevention of venous thromboembolism (VTE), uncertainty remains regarding their …
Anticoagulation for the long‐term treatment of venous thromboembolism in patients with cancer
… with VKA reduces venous thromboembolic events but not mortality. The decision for a patient
with cancer and VTE to start long‐term LMWH versus oral anticoagulation should balance …
with cancer and VTE to start long‐term LMWH versus oral anticoagulation should balance …
Long-term treatment of venous thromboembolism
… with 5 years of extended anticoagulation vs no anticoagulation in patients with different …
deaths with 5 years of extended anticoagulation vs no anticoagulation in patients with different …
deaths with 5 years of extended anticoagulation vs no anticoagulation in patients with different …
Duration of anticoagulation following venous thromboembolism: a meta-analysis
D Ost, J Tepper, H Mihara, O Lander, R Heinzer, A Fein - Jama, 2005 - jamanetwork.com
… using the terms venous thromboembolism or pulmonary … or anticoagulant(s) or anticoagulant
treatment or anticoagulant therapy or duration of anticoagulant therapy or anticoagulation. …
treatment or anticoagulant therapy or duration of anticoagulant therapy or anticoagulation. …
Treatment of venous thromboembolism
… The duration of oral anticoagulant therapy after a second episode of venous … control VTE
population (risk ratio, 2.1; 95% CI, 1.3-3.3) within 4 years following cessation of anticoagulation; …
population (risk ratio, 2.1; 95% CI, 1.3-3.3) within 4 years following cessation of anticoagulation; …
Impact of venous thromboembolism and anticoagulation on cancer and cancer survival
NM Kuderer, TL Ortel, CW Francis - Journal of Clinical Oncology, 2009 - ascopubs.org
… Patients with cancer have a substantially increased risk of venous thromboembolism (VTE) …
Furthermore, intriguing in vitro and animal findings suggest that anticoagulants, in particular …
Furthermore, intriguing in vitro and animal findings suggest that anticoagulants, in particular …
Venous thromboembolism: advances in diagnosis and treatment
… D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism:
… unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. …
… unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. …
Duration of anticoagulation after venous thromboembolism in real world clinical practice
… Venous thromboembolism (VTE) carries a considerable risk of recurrence and anticoagulants
should be administered for a minimum of three months. Since little is known about real life …
should be administered for a minimum of three months. Since little is known about real life …
[HTML][HTML] Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta‐analysis of controlled …
M Paciaroni, G Agnelli, M Venti, A Alberti… - Journal of Thrombosis …, 2011 - Elsevier
… of anticoagulation in prevention of venous thromboembolism in patients with ICH because
the use of anticoagulants … To further clarify the role of anticoagulants (unfractionated heparin […
the use of anticoagulants … To further clarify the role of anticoagulants (unfractionated heparin […
Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
LA Kahale, MB Hakoum, IG Tsolakian… - Cochrane Database …, 2018 - cochranelibrary.com
… The decision for a person with cancer and venous thromboembolism (VTE) to start long‐term
low molecular weight heparin (LMWHs) treatment or oral anticoagulation treatment should …
low molecular weight heparin (LMWHs) treatment or oral anticoagulation treatment should …
相关搜索
- prevention of venous thromboembolism controlled studies
- management of venous thromboembolism
- venous thromboembolism meta analysis
- venous thromboembolism anticoagulant therapy
- venous thromboembolism long term treatment
- acute venous thromboembolism
- venous thromboembolism duration of anticoagulation
- venous thromboembolism direct oral anticoagulants
- venous thromboembolism major bleeding
- venous thromboembolism command vte registry
- prophylaxis of venous thromboembolism
- venous thromboembolism risk factors
- anticoagulant treatment of venous thromboembolism
- cancer survival venous thromboembolism and anticoagulation
- idiopathic venous thromboembolism extended anticoagulation
- unprovoked venous thromboembolism indefinite anticoagulation